Lumeris Is Leveraging Google Cloud's Platform To Launch AI Powered Primary Care Services
Primary care is one of the most important pillars of healthcare.
Lumeris announced today that it will be partnering with Google Cloud to build and advance a cutting-edge primary-care-as-a-service platform. Specifically, Lumeris' Tom platform will leverage Google Cloud's AI models and infrastructure to embed directly within primary care workflows in order to independently assess and execute the next best action for patients, including: automatically checking in on high risk patients and tracking recurrent complaints, scheduling follow up screenings, engaging in patient outreach, monitoring medication compliance and even working with patients to ensure emergent complaints are immediately flagged for follow up.
Google Cloud's incredible progress in AI will unlock an entirely new set of capabilities for Tom and the general primary care workflow. CEO and leader of Google Cloud, Thomas Kurian, explains that AI has transformed care and democratized healthcare access; "By combining Google Cloud's AI capabilities with Lumeris' decades of primary care insight, we can provide doctors and nurses with the AI support and insights they need to help improve care for their patients.'
Dr. David Carmouche, EVP and chief clinical transformation officer of Lumeris, comments that the company has had an opportunity over the last two decades to work with an incredible amount of healthcare data and has invested significant resources to marry disparate datasets and glean insights. Now, with Google Cloud's tools, the value from this data can be advanced to an entirely elevated level of ROI.
Aashima Gupta, global director for healthcare strategy and solutions at Google Cloud, explains that the collaboration will enable Lumeris' platform to leverage Gemini and its multimodal/voice recognition technology alongside Google Cloud's wider AI infrastructure; this will advance Tom's semantic search capabilities, agentic development and infrastructure needs, deep research capabilities, and most importantly, provide a highly advanced privacy and security overlay.
John Doerr, chairman of Kleiner Perkins and board member of Lumeris, comments that "the human toll of the primary care shortage is staggering—missed diagnoses, delayed treatments, and inferior outcomes…Google and Lumeris are bringing their unique capabilities together to help solve this crisis. We have both the means and the resolve to dramatically improve care for hundreds of millions of Americans.'
Indeed, the collaboration comes at a time when primary care continues face a massive physician shortage alongside mounting administrative burdens and workflow challenges. Studies have indicated that primary care will experience a projected shortage of nearly 87,000+ physicians by 2037. Surveys also show that 79% of primary care physicians report burnout, citing a variety of reasons including the lack of disconnecting from work, ever-growing patient demands and the numerous administrative metrics that they are beholden to.
This is why large companies are investing billions of dollars in primary care. For example, CVS Health has invested significant resources in its primary care business as a means to leverage its community presence and provide clinical services to customers. Walgreens also pursued a similar effort with VillageMD at one point, but faced numerous market challenges.
Indeed, in light of these challenges, many industry leaders are increasingly turning to technology with the hopes that it can help alleviate some of these burdens-- not just to expand primary care services through opening more brick-and-mortar practices, but also by helping mitigate the burden on the existing workforce. Lumeris' partnership with Google Cloud aims to do exactly this: combine its existing healthcare expertise with incredible technological advancements to scale its impact even further.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
an hour ago
- UPI
Sen. Rand Paul 'not an absolute no' on budget bill
Sen. Rand Paul, R-KY, speaks during a Senate Health, Education, Labor and Pensions Committee hearing on Martin Makary's nomination to be Commissioner of the Food and Drugs Administration at the U.S. Capitol in Washington, D.C., in March. File photo by Bonnie Cash/UPI | License Photo June 15 (UPI) -- Sen. Rand Paul, R-Ky., said Sunday that he is "not an absolute no" on the Trump administration's House-passed budget reconciliation bill, which threatens cuts to social services and would increase the national spending deficit. "I talked to the president last evening after the parade, and we're trying to get to a better place in our conversations," Paul said on NBC News' Meet the Press Sunday. "And I've let him know that I'm not an absolute no." Paul has been a leading critic of the bill in its current form, along with a handful of other Republicans skeptical of the scope of the cuts. A report from the nonpartisan Congressional Budget Office report that shows that the measure would come at the expense of lower income Americans to benefit higher earners. "I don't have as much trouble with the tax cuts," Paul continued. "I think there should be more spending cuts, but if they want my vote, they'll have to negotiate," specifically citing his opposition to raising the debt ceiling by trillions of dollars. In its current form, the measure would increase the national deficit by $2.4 trillion over 10 years. Lawmakers are trying to pass the bill through a reconciliation process that only requires a simple majority for passage. Paul said last week that tensions have come to the fore between him and his GOP colleagues, and that he was "uninvited" to a White House picnic that is typically attended by lawmakers and their families. He called the move "petty vindictiveness," and said he felt the White House was trying to "punish" him for his opposition to the bill as it stands. President Donald Trump said on his social media platform that "of course" Paul was invited to the picnic. Republicans can only afford to lose three votes pending a tie breaking vote by Vice President JD Vance. The measure currently awaits action in the Senate, where Republicans hold 53 seats. The body has taken a more conservative approach in the negotiations than the House.
Yahoo
an hour ago
- Yahoo
Grant Cardone Says 'Consumer Debt Makes Slaves.' It Stops You From Investing, Costs You More, And Chains You To Stress
Real estate mogul Grant Cardone has made his stance on consumer debt crystal clear. In a recent post on X, the real estate mogul and motivational speaker warned that debt doesn't just slow people down financially—it traps them. 'Consumer debt makes slaves!' Cardone wrote. He broke it down into five main consequences: 'Can't invest, can't keep up, pay extra for everything, can't build net worth, never live stress free.' Don't Miss: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can Cardone's post reflects a growing concern in the U.S. as consumer debt keeps climbing. According to LendingTree (NASDAQ:TREE), Americans owed a record $251 billion in personal loan debt as of the fourth quarter of 2024. That's a $6 billion jump from the year before. And it's not just the total amount. TransUnion (NYSE:TRU) data shows that the number of Americans with personal loans hit 24.5 million, up from 23.5 million a year earlier. While personal loan debt still makes up just 1.4% of all consumer debt, it accounts for 5% of non-mortgage debt. For comparison, credit card debt is much higher, sitting at $1.211 trillion, or 6.7% of total outstanding debt. According to TransUnion, the average personal loan balance per borrower is $11,607. Nearly half of borrowers take out loans just to consolidate or refinance other debt. Another 10% use the money to pay everyday bills. Trending: Invest where it hurts — and help millions heal:. As Cardone wrote, 'You pay extra for everything' when you're stuck in debt. High interest rates only make it worse. Borrowers with excellent credit scores — over 720 — can expect personal loan APRs around 17.71%. But for those with poor credit — below 560 — rates skyrocket to over 200%, according to LendingTree data. Despite high costs, personal loan use is expected to grow. People turn to them as credit card debt rises. LendingTree notes that many borrowers aren't necessarily in crisis—they might be remodeling a home or covering a big expense. Still, as Cardone puts it, for those already stretched thin, more borrowing can result in serious stress and financial strain. Delinquency rates also tell a cautionary tale. TransUnion reported that as of Q4 2024, 3.57% of personal loan accounts were 60 or more days past due. That's an improvement from the year before but still higher than rates for mortgages — 1.29% — or credit cards — 2.56%. Cardone's message is harsh but timely. With debt balances climbing and millions relying on personal loans to stay afloat, his warning resonates: consumer debt doesn't just drain your wallet—it can drain your peace of mind. Read Next: Maximize saving for your retirement and cut down on taxes: . The average American couple has saved this much money for retirement —?UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? LENDINGTREE (TREE): Free Stock Analysis Report TRANSUNION (TRU): Free Stock Analysis Report This article Grant Cardone Says 'Consumer Debt Makes Slaves.' It Stops You From Investing, Costs You More, And Chains You To Stress originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
The Hill
3 hours ago
- The Hill
How Kennedy's overhaul could make vaccines more expensive
Health and Human Services Secretary Robert F. Kennedy Jr.'s moves to upend decades of vaccine policy could hit patients hardest in their wallets, as shifting guidance over shots could make insurance coverage confusing and scattershot. For decades, the Centers for Disease Control and Prevention's (CDC) independent advisory panel recommended which shots Americans should get and when. The Affordable Care Act requires all insurance companies to cover, for free, all vaccines the panel recommends. Those recommendations also help states decide which shots should be mandated for schoolchildren. Kennedy's most recent move to purge the entire advisory panel and replace them with his own handpicked members, including several vocal vaccine critics, is throwing that process into doubt. 'If we have a system that has been dismantled — one that allowed for open, evidence-based decisionmaking and that supported transparent and clear dialogue about vaccines — and then we replace it with a process that's driven largely by one person's beliefs, that creates a system that cannot be trusted,' Helen Chu, a newly ousted member of the panel and professor of infectious disease at the University of Washington School of Medicine, said during a press conference. Vaccine prices vary, but without insurance, coronavirus vaccines can cost nearly $150, the MMR shot ranges from $95 to nearly $280, and the HPV vaccine can exceed $300, according to CDC data. Individual pharmacies could charge even more. Candace DeMatteis, policy director at the Partnership to Fight Infectious Disease, said she worries about creating a two-tiered system. 'Out of pocket costs for vaccines become an issue where we could end up with a system where some people can afford vaccinating themselves and their families and others cannot,' DeMatteis said. Prior to enactment of the Affordable Care Act, vaccine coverage varied significantly depending on the type of insurance a person had. If the CDC's Advisory Committee on Immunization Practices (ACIP) changes recommendations for existing vaccines or doesn't recommend new ones, maintaining access will be difficult. 'It's a seismic shift, if you will, away from facilitating access by removing coverage and cost barriers, to one where there's great uncertainty and coverage and cost issues become barriers,' DeMatteis said. It's not clear what the vetting process was for the eight people Kennedy appointed to the ACIP, or how prepared they will be for their first meeting, which is scheduled to occur in less than two weeks. According to a Federal Register notice, the panel is scheduled to vote on recommendations for COVID-19 vaccines as well as meningococcal, HPV, influenza, and RSV vaccines for adults and maternal and pediatric populations. Health experts said they have serious questions about what direction the new panel will take and whether Americans will still have access to free vaccines, including the coronavirus shot, in time for fall respiratory season. If the ACIP is no longer a reliable, independent authority on vaccines, it 'will be replaced by a patchwork of different policies by different states, and each state will have to make its own decisions,' Chu said. 'Washington state is a place where we have experts and scientists who work together. There are other states where this may not exist, or where they may not choose to recommend vaccines. So that is going to create a lot of chaos,' she added. Some state health officials have already begun taking steps in that direction. The Illinois Department of Health said on social media it will be convening its own vaccine advisory committee and national experts 'to ensure we continue to provide clear, science-backed vaccine guidance for our residents.' When Kennedy unilaterally changed the COVID-19 vaccine guidance earlier this month to remove recommendations for pregnant women and change the open recommendation for children, the Wisconsin Department of Health Services said it would continue to recommend the shots for every person at least 6 months old. 'The recent changes in CDC guidance were not made based on new data, evidence, or scientific or medical studies, nor was the guidance issued following normal processes,' the agency said in a statement. Tina Tan, president of the Infectious Diseases Society of America, said her organization as well as other major medical groups including the American Medical Association and the American Academy of Pediatrics Academy have been speaking with insurance companies to urge them to continue paying for shots, even if the panel changes recommendations. Tan mentioned an initiative launched in April by a group of public health experts called the Vaccine Integrity Project, which is working to create an alternative process to maintain vaccine access. The initiative is funded by a foundation backed by Walmart heiress Christy Walton and led by Michael Osterholm, director of the University of Minnesota's Center for Infectious Disease Research and Policy. Federal law is specific that insurance provisions are tied to the ACIP. Specialty organizations may have expertise to make their own recommendations, but they will still require the cooperation of insurance companies. States are also more limited, and they don't have the same power as the federal government to force coverage. 'I think it remains to be seen what the insurers are going to do,' Tan said. 'However, hopefully, with the discussions going on, they can get the insurers to understand that vaccines are extraordinarily safe and effective and are the best tool that we have to protect persons of all ages against serious vaccine preventable diseases.'
